![Jun Gong: Dr. Martijn Meijerink’s Phase III COLLISION trial less than 10 colorectal liver metastases](https://oncodaily.com/pub/uploads/2024/06/Pi7_Tool_406_fullimage_meijerink-martijn-r.-25457-3380-ala-amsterdam-umc-1.jpg)
Photo of Martijn Meijerink from vumc.nl
Jun 4, 2024, 04:06
Jun Gong: Dr. Martijn Meijerink’s Phase III COLLISION trial less than 10 colorectal liver metastases
Jun Gong, Medical oncologist and researcher in gastrointestinal and genitourinary cancers at Cedars-Sinai, shared a post on X:
“Dr. Meijerink Phase III COLLISION trial less than 10 colorectal liver metastases (CRLMs) 1:1 resection versus ablation showed similar overall survival (OS), not different in local and distant recurrence.
Both arms got 20-23% chemotherapy, mean tumor size < 20 mm, low tumor burden.”
Source: Jun Gong/X
Aug 15, 2024, 07:34